Startups pioneering less-invasive technologies to treat common eye diseases are changing the outlook for both patients and the industry. A new study by CB Insights revealed that investors have been pouring money into smaller companies in 2017 and 2018, with some FDA approvals to begin marketing their technologies and treatments. These firms are eyeing conditions […]
Report: Drug delivery investments down in Q3
Investment spending in the drug delivery sector has dropped significantly for the third quarter, but is staying ahead of last years numbers for the first through third quarters, according to a new report. Venture capital investments fell a significant 61.8% to $29.6 million during the three months ended September 30, though deal volume stayed the […]
Report: Medical device deal volume, spend down during Q3
Investors spent less money on fewer deals in the medical device sector during the third quarter and so far this year, bucking the overall growth trend for venture capital-backed firms, according to a new report. Venture capital investment fell -19.7% to $772.7 million during the three months ended Sept. 30, with deal volume down -20.3% […]
Report: Q3 2017 Healthcare VC funding steady, digital health deals drop
Venture Capital funding in the healthcare sector during the third quarter of 2017 stayed mostly in line with the previous quarter while digital health deals saw a significant drop, according to a PricewaterhouseCoopers and CB Insights MoneyTree report. VC funding during the third quarter of 2017 was directly in line with the previous quarter, but […]
Report: Medtech led the way last year in healthcare VC deals
It was a very good year for venture capital investment in the medical device industry, according to research firm CB Insights.
Ishrak: ‘With COV We’ll do for ORs what we’ve done for cath labs’ | The week in medtech M&A
CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014
At least 4 medtech exits were significant enough to make the cut for the top 20 venture capital-backed healthcare exits of 2014, according to research firm CB Insights.
Medical device deals led Q1 VC healthcare activity
Click image to enlarge. © 2014 CB Insights
The surge of medical device IPOs during the 1st quarter wasn’t mirrored by venture capital investment, although medtech firms tied for the most number of healthcare deals during the quarter, according to CB Insights.
Medical device and biotech VC transactions each accounted for 27% of healthcare deals during the quarter, according to the data consulting firm.
Medical Device Venture Capital Report for January 2013
Medical device companies pulled in more than $255 million from investors in 29 deals during January, according to data provided to MassDevice.com by CB Insights Inc.
The deals ranged widely in size, from a $25,000 seed round investment for Elyira, Ohio-based Guided Interventions and its passive coronary artery blockage sensing technology to a $43 million Series D round for EndoChoice and its endoscopes.
Medical device angel investments jump in 2012
The medical device industry isn’t being left behind when it comes to angel investing, according to data provided to MassDevice.com from the investment data firm CB Insights.
Angel- and seed-round financing (typically $1.5 million or less) jumped dramatically in 2012, accounting for about 27% of all investment in the medical device industry. That’s a 50% increase compared with 2011.
Venture capital: Deal flow jumps during 4th quarter of 2012
Investors returned to the medical device industry during the final quarter last year, despite negative headwinds, according to new data released by CB Insights, a venture capital and angel investment database.
Companies in the medical device space closed 68 deals during the final 3 months of 2012, up 41% from the previous quarter about 3% from the same period in 2011, making Q4 the most active quarter of 2012.
